Who owns Bridgebio Pharma Inc (BBIO)?
239 US mutual funds and ETFs from 132 fund families reported a position in BBIO for the quarter ending 2026-06-30. Against their own report a quarter earlier, 85 raised shares, 49 opened a new position, 71 cut and 58 sold out.
Largest fund families
| Fund family | Funds | Share of fund-held shares |
|---|---|---|
| Vanguard Index Funds | 4 | 36.3% |
| Janus Investment Fund | 7 | 15.2% |
| Ishares Trust | 10 | 10.3% |
| Spdr Series Trust | 2 | 3.8% |
| Jpmorgan Trust Ii | 1 | 3.0% |
| Jnl Series Trust | 7 | 2.2% |
Tracked managers holding BBIO
| Investor | Book weight |
|---|---|
| Andreas Halvorsen · Viking Global | 2.1% |
Source: SEC Form N-PORT, which funds file about 60 days after quarter end, and the latest 13F filings. Share counts, not trades: a change can reflect fund inflows or outflows rather than a decision about BBIO. A record of holdings, not a forecast and not investment advice. See all owner pages or the forecast board for the names our model ranks.
Our model ranks every tracked manager’s likely next buys from 13F filings. Request the dataset sample with a work email.
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.